Completion of Disposal

RNS Number : 9477Q

Genedrive PLC

11 June 2018

 

For release: 11 June 2018

genedrive plc ("genedrive" or the "Company")

Completion of Disposal

Further to the announcement on 14^th May 2018 and shareholder approval at the General Meeting on 4^th June, genedrive plc is pleased to announce that it has now completed the sale of its contract research and pharmacogenomics divisions for an aggregate cash consideration of up to £1.9m.

-  Ends  -

For further details please contact:

genedrive plc

David Budd: CEO                                                                                                         [phone]

Matthew Fowler: CFO

Peel Hunt LLP

James Steel                                                                                                                    [phone]

Oliver Jackson

Stanford Capital Partners Limited                                                                        [phone]

Patrick Claridge               

Consilium Strategic Communications

Chris Gardner                                                                                                                [phone]

Matthew Neal

Laura Thornton

[e-mail] 

Notes to Editors

About genedrive plc

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® HCV-ID test has received CE-IVD Certification and has been launched in Africa and Asia Pacific. genedrive has distribution agreements with subsidiaries of Sysmex Corporation for the distribution of the Genedrive® platform in the EMEA  and SE Asia (ex India), and with ARKRAY Healthcare pvt Ltd for the distribution of the Genedrive® HCV ID Kit and Genedrive® platform in India.

Further details can be found at: www.genedriveplc.com and www.genedrive.com

 

END

 

 

DISVFLBFVQFLBBX